Abstract
Despite the introduction of drug-eluting stents restenosis remains an important clinical problem. In this review we examine the role of plasminogen activator inhibitor-1 (PAI-1) in controlling restenosis after balloon angioplasty and stent implantation.
Keywords: Urokinase, vascular wall, restenosis, carotid artery ligation, VSMC proliferation
Current Drug Targets
Title: Plasminogen Activator Inhibitor-1 and Restenosis
Volume: 8 Issue: 9
Author(s): Nadish Garg and William P. Fay
Affiliation:
Keywords: Urokinase, vascular wall, restenosis, carotid artery ligation, VSMC proliferation
Abstract: Despite the introduction of drug-eluting stents restenosis remains an important clinical problem. In this review we examine the role of plasminogen activator inhibitor-1 (PAI-1) in controlling restenosis after balloon angioplasty and stent implantation.
Export Options
About this article
Cite this article as:
Garg Nadish and Fay P. William, Plasminogen Activator Inhibitor-1 and Restenosis, Current Drug Targets 2007; 8 (9) . https://dx.doi.org/10.2174/138945007781662355
DOI https://dx.doi.org/10.2174/138945007781662355 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Opportunities for Pharmacotherapy at the Intersection of Metabolic Syndrome and Hemostasis
Current Pharmaceutical Biotechnology Melatonin and its Relationships with Diabetes and Obesity: A Literature Review
Current Diabetes Reviews Subject Index To Volume 9
Current Medicinal Chemistry Polyphenols from Red Wine Modulate Immune Responsiveness: Biological and Clinical Significance
Current Pharmaceutical Design Pharmacology and Perioperative Considerations for Diabetes Mellitus Medications
Current Clinical Pharmacology Coronary Risk Assessment and Management Options in Chronic Kidney Disease Patients Prior to Kidney Transplantation
Current Cardiology Reviews Lassa Virus Genome
Current Genomics Antioxidant Capacity, Phytochemical Analysis and Identification of Active Compounds in Anchomanes difformis
The Natural Products Journal Potential Role of Endothelin in Early Vascular Aging
Current Hypertension Reviews Hypertensive Treatment and the Metabolic Syndrome
Current Hypertension Reviews Application of NMR Spectroscopy in Medicinal Chemistry and Drug Discovery
Current Topics in Medicinal Chemistry Emerging Role for Antioxidant Therapy in Protection Against Diabetic Cardiac Complications: Experimental and Clinical Evidence for Utilization of Classic and New Antioxidants
Current Cardiology Reviews Molecular Docking Simulations as a Prominent Tool to Envisage the Preformulation Perspectives of Oral Hypoglycaemic Agents with β-cyclodextrin
Letters in Drug Design & Discovery Vulnerable Plaque and Inflammation: Potential Clinical Strategies
Current Pharmaceutical Design Progresses in Nanopores Fabrications and Nanopore Sequencing
Nanoscience & Nanotechnology-Asia Melatonin and Renal Protection: Novel Perspectives from Animal Experiments and Human Studies (Review)
Current Pharmaceutical Design Immune Function in Pregnant Women with Affective Disorders
Current Psychiatry Reviews Pharmacological Management of Diabetic Nephropathy
Current Vascular Pharmacology A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer’s Disease
Current Drug Metabolism Obesity and Body Composition in Man and Woman: Associated Diseases and the New Role of Gut Microbiota
Current Medicinal Chemistry